RCUS Arcus Biosciences, Inc.

HealthcareBiotechnology
$24.80
4.63%
38
QScore Signal
Short
Confidence: MEDIUM
Long-Term
27
Short-Term
49

Value

18
P/E-8.43
8
P/B5.93
44
P/S10.58
21
EV/EBITDA-7.02
5

Growth

29
Revenue Growth-4.3%
17
EPS Growth-4.8%
43
FCF Growth-175.0%
25

Momentum

82
12-Month Return205.2%
100
3-Month Return23.7%
98
1-Month Return9.4%
70
RSI (14)52.24
54
50/200 MABullish
75

Profitability

19
ROE-69.0%
38
ROA-37.0%
0
Gross Margin90.7%
72
Operating Margin-168.6%
0
Net Margin-156.4%
0
FCF Yield-19.6%
0

Risk

34
Beta0.87
75
60-Day Volatility68.2%
0

Generated 5/7/2026, 10:01:14 PM · How is this calculated?

QScore Analysis